Clinical Study Designed to Evaluate the Effect of CimetrA in Patients Diagnosed With COVID-19
Clinical trial NCT04802382 · UNKNOWN
Trial details
- NCT number
- NCT04802382
- Sponsor
- MGC Pharmaceuticals d.o.o
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-11
- Primary completion
- 2023-02-01
- Enrollment
- 252
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.